|
Polysorbate positive |
Polysorbate positive |
1/7 |
|
Polysorbate negative |
Polysorbate negative |
6/7 |
|
Macrogol negative |
Macrogol negative |
12/12 |
|
Tromethamine negative |
Tromethamine negative |
1/1 |
Administered vaccine |
Administered vaccine |
Administered vaccine |
Administered vaccine |
|
Comirnaty® |
Comirnaty® |
57/69 |
|
Jcovden® |
Jcovden® |
9/69 |
|
Vaxzevria® |
Vaxzevria® |
3/69 |
Symptoms immediately after vaccination |
Symptoms immediately after
vaccination |
Symptoms immediately after vaccination |
2/69 |
|
|
Anaphylaxis (dyspnea, urticaria) |
1/2 |
|
|
Urticaria |
1/2 |
Symptoms after administration of placebo |
Symptoms after administration
of placebo |
Symptoms after administration of placebo |
19/69 |
|
|
Subjective feeling of pharyngeal swelling |
4/19 |
|
|
Generalized malaise |
4/19 |
|
|
Headache |
3/19 |
|
|
Pruritus |
3/19 |
|
|
Thoracal pain |
3/19 |
|
|
Nausea |
4/19 |
|
|
Syncope |
1/19 |
|
|
Palpitations |
4/19 |
Symptoms after placebo per referral group |
Symptoms after placebo per
referral group |
Symptoms after placebo per referral group |
Symptoms
after placebo per referral group |
|
|
Anxiety |
4/23 |
|
|
Symptoms after 1st or 2nd dose |
14/41 |
|
|
Multiple anaphylaxis |
0/1 |
|
|
Refused by vaccination center |
1/4 |